Condition: Glioma, Malignant · Metastases to Brain · Sponsor: Sklifosovsky Institute of Emergency Care
Objective of the study is to determine whether combined use of intraoperative fluorescence with 5-aminolevulinic acid (5-ALA) and sonography can achieve higher rate of gross total resection of contrast-enhancing gliomas and brain metastases compared to intraoperative fluorescence with 5-ALA alone.
This description comes directly from the study's public registry record.
Alexander Dmitriev, MD · +7 (916) 423-54-08 · dmitriev@neurosklif.ru
Always discuss trial participation with your own doctor first.
| Sklifosovsky Institute of Emergency Care | Moscow, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05474573